Literature DB >> 21632065

Correlation of cerebral spinal fluid pH and HCO3- with disease progression in ALS.

Nobutoshi Morimoto1, Kentaro Deguchi, Kota Sato, Taijun Yunoki, Shoko Deguchi, Yasuyuki Ohta, Tomoko Kurata, Yoshiki Takao, Yoshio Ikeda, Tohru Matsuura, Koji Abe.   

Abstract

Amyotrophic lateral sclerosis (ALS) is a progressive and fatal disease, which is characterized by progressive degeneration of spinal and bulbar innervating motor neurons. However, the underlying mechanisms of motor neuron death remain poorly understood. Several candidate disease biomarkers have been detected in cerebrospinal fluid of ALS patients. The present study analyzed various cerebral spinal fluid gas parameters in ALS patients and compared these values to controls, as well as patients with cervical spondylosis, Parkinson syndrome, and spinocerebellar degeneration. Cerebral spinal fluid pH positively correlated with the ALS functional rating scale in total and limb-type ALS patients. In addition, cerebral spinal fluid pH positively correlated with shorter disease duration (less than 22 weeks). These results suggested that cerebral spinal fluid pH provides a biomarker for ALS and could reflect mechanisms of disease progression in ALS patients.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21632065     DOI: 10.1016/j.jns.2011.05.013

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  2 in total

1.  Study of conformational transitions of i-motif DNA using time-resolved fluorescence and multivariate analysis methods.

Authors:  Sanae Benabou; Cyril Ruckebusch; Michel Sliwa; Anna Aviñó; Ramon Eritja; Raimundo Gargallo; Anna de Juan
Journal:  Nucleic Acids Res       Date:  2019-07-26       Impact factor: 16.971

Review 2.  Ventilatory control in ALS.

Authors:  Nicole L Nichols; J Van Dyke; L Nashold; I Satriotomo; M Suzuki; G S Mitchell
Journal:  Respir Physiol Neurobiol       Date:  2013-05-18       Impact factor: 1.931

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.